Neal D. Shore, MD

Neal D. Shore, MD

Episodes

Specialty:

All

Year:

All

EP. 1: Combining and Sequencing Sipuleucel-T in CRPC

May 17th 2015

EP. 2: AUA2015: Biomarkers, Enzalutamide, and ARN509

May 17th 2015

EP. 3: Reassessing Trial Endpoints for CRPC

May 17th 2015

EP. 4: Administering Radium-223 for mCRPC

May 17th 2015

EP. 5: Reducing Skeletal-Related Events in Prostate Cancer

May 17th 2015

EP. 6: Symptomatic Bone Lesions in CRPC: More Options for Treatment

May 17th 2015

EP. 7: Asymptomatic Versus Symptomatic Bone Metastases in Prostate Cancer

May 17th 2015

EP. 8: Biomarkers Indicative of Bone Lesions in Prostate Cancer

May 17th 2015

EP. 9: Bone Metastases in CRPC: Prognostic for Survival

May 17th 2015

Trending on OncLive

FDA Grants Breakthrough Therapy Designation to 64Cu-SAR-bisPSMA for PSMA PET in Biochemically Recurrent Prostate Cancer

Detalimogene Responses Improve With Longer Follow-Up in BCG-Unresponsive NMIBC Ahead of BLA Submission

Combination Therapy Overcomes Treatment Resistance in Breast Cancer Models

Dr Wander on the Evolving First-Line and Post–T-DXd Landscape in HER2+ Metastatic Breast Cancer

Dr Levy on Where Iza-Bren May Fit Following Osimertinib In EGFR-Mutated NSCLC